Nonautologous gene therapy with implantable devices.
Chang
P L
PL
Department of Pediatrics, McMaster University, Hamilton, Ontario. changP@fhs.McMaster.CA
D000818:Animals; D001672:Biocompatible Materials; D002214:Capsules; D002478:Cells, Cultured / Q000637:transplantation; D004195:Disease Models, Animal; D005164:Factor IX / Q000378:metabolism; D005786:Gene Expression Regulation; D030342:Genetic Diseases, Inborn / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D013006:Growth Hormone / Q000172:deficiency; D019382:Human Growth Hormone / Q000378:metabolism; D020007:Implants, Experimental; D016464:Lysosomal Storage Diseases / Q000235:genetics / Q000628:therapy; D008768:Methylmethacrylates; D051379:Mice; D008970:Molecular Weight; D010539:Permeability; D011102:Polyhydroxyethyl Methacrylate; D019736:Prostheses and Implants; D011506:Proteins; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000235:genetics; D014162:Transfection
D001672:Biocompatible Materials; D002214:Capsules; D008768:Methylmethacrylates; D011506:Proteins; D011994:Recombinant Proteins; D019382:Human Growth Hormone; D011102:Polyhydroxyethyl Methacrylate; C040206:HTR composite; D005164:Factor IX; D013006:Growth Hormone